Heavy menstrual bleeding in women with inherited bleeding disorders

fibrinolysis in women with heavy menstrual bleeding

Treatment of heavy menstrual bleeding

Jane Clarke research fellow, Department of Obstetrics and Gynaecology , University of Auckland, Grafton, Auckland 1010, New Zealand [email protected] Competing interests: The author has completed the Unified Competing Interest form at www.icmje.org/coi_disclosure. pdf (available on request from the corresponding author) and declares: (1) No financial support for the submitted work from an...

Controversies in Inherited Bleeding Disorders.

Recent years are witnessing key developments in treatment approaches for congenital bleeding disorders (CBD), in particular the hemophilias, but also other factor deficiencies.1,2 Moreover, cooperative multinational efforts are providing advances in our knowledge of pathophysiological, clinical, and management aspects of these disorders, including the more rare abnormalities.3–6 However, despit...

Gynecological and obstetrical manifestations of inherited bleeding disorders in women.

Patients affected by bleeding disorders present a wide spectrum of clinical symptoms that vary from a mild or moderate bleeding tendency to significant episodes. Women with inherited bleeding disorders are particularly disadvantaged since, in addition to suffering from general bleeding symptoms, they are also at risk of bleeding complications from regular haemostatic challenges during menstruat...

Medical management of heavy menstrual bleeding

Women with benign heavy menstrual bleeding have the choice of a number of medical treatment options to reduce their blood loss and improve quality of life. The role of the clinician is to provide information to facilitate women in making an appropriate choice. Unfortunately, many options can be associated with hormonal side effects, prevention of fertility and lack of efficacy, leading to disco...